Gül Karakaya

1. Rapid Drug Desensitization to Platinum-based Chemotherapy Agents: A Single-center ExperienceKAYIKÇI H., DAMADOĞLU E., CİHANBEYLERDEN M., Tüccar Ç., Ustaoğlu A. P., ÇAYIRÖZ K., et al.Thoracic Research and Practice, cilt.27, sa.5, ss.317-323, 2026 (ESCI, Scopus, TRDizin)
2. The association between baseline IgE level and urticaria control at six months of omalizumab treatment in chronic urticariaTUNCAY G., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.European Annals of Allergy and Clinical Immunology, cilt.58, sa.3, ss.126-133, 2026 (ESCI, Scopus)
3. Clinical outcomes and risk factors associated with breakthrough reactions in chemotherapy desensitizationKAYIKÇI H., DAMADOĞLU E., CİHANBEYLERDEN M., Tuccar C., Pehlivanlar Ustaoglu A., ÇAYIRÖZ K., et al.Allergy and asthma proceedings, cilt.47, sa.3, ss.216-224, 2026 (SCI-Expanded, Scopus)
4. Comparison of the characteristics of patients with chronic urticaria receiving standard-or high-dose omalizumabTUNCAY G., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.European Annals of Allergy and Clinical Immunology, cilt.58, sa.2, ss.69-76, 2026 (ESCI, Scopus)
5. Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic UrticariaKAYIKÇI H., DAMADOĞLU E., Cihanbeylerden M., Tüccar Ç., Ustaoğlu A. P., KARAKAYA G., et al.Allergy: European Journal of Allergy and Clinical Immunology, cilt.81, sa.1, ss.267-270, 2026 (SCI-Expanded, Scopus)
6. Hereditary angioedema care across selected health systems in the Balkan Peninsula area: policy gaps, practice variation, and actionable recommendationsKonstantinou G. N., Andrejevic S., Angjeleska N., Karakoc-Aydiner E., Bara N. A., Barešić M., et al.Frontiers in Allergy, cilt.7, 2026 (ESCI, Scopus)
7. Comparison of Clinical Characteristics Between Hereditary Angioedema Patients Aged 65 Years and Older and Those Under 65: A Perspective on Elderly PatientsTuncay G., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.Life, cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)
8. Identifying future risk factors of uncontrolled asthma control: the TAAR study perspectiveBOZKURT N., Abadoglu O., Onaran A. B. O., GÖKMEN D., Buhari G. K., AYDIN Ö., et al.Journal of Asthma, cilt.63, sa.3, ss.339-349, 2026 (SCI-Expanded, Scopus)
9. Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1Lumry W. R., Tachdjian R., Craig T., KARAKAYA G., Gelincik A., Stobiecki M., et al.Journal of Asthma and Allergy, cilt.19, 2026 (SCI-Expanded, Scopus)
10. What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma RegistryKIZILIRMAK D., Uzun O., GÖKMEN D., AYDIN Ö., BAŞYİĞİT İ., DURSUN A. B., et al.BRATISLAVA MEDICAL JOURNAL, cilt.126, ss.1008-1022, 2025 (SCI-Expanded, Scopus)
11. Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic UrticariaCihanbeylerden M., Teixeira J., Kayikci H., Tuccar C., Kalyoncu A. F., Damadoglu E., et al.ALLERGY, cilt.80, sa.5, ss.1495-1497, 2025 (SCI-Expanded, Scopus)
12. Clinical characteristics and biological treatment responses of patients with late-onset asthma phenotypeKAYIKÇI H., DAMADOĞLU E., CİHANBEYLERDEN M., Tuccar C., KARAKAYA G., KALYONCU A. F.ALLERGY AND ASTHMA PROCEEDINGS, cilt.46, sa.2, ss.109-118, 2025 (SCI-Expanded, Scopus)
13. Evaluation of Risk Factors Causing Diagnostic Delay in Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory DiseaseCİHANBEYLERDEN M., KAYIKÇI H., Tuccar C., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.THORACIC RESEARCH AND PRACTICE, cilt.26, sa.2, ss.77-84, 2025 (ESCI, Scopus, TRDizin)
14. Trends in prescribing montelukast in patients with asthma in real-life: Results from the Turkish adult asthma registryBeyaz S., Erdinc M., HAYME S., Aslan A. F., Aydin O., Gokmen D., et al.ALLERGOLOGIA ET IMMUNOPATHOLOGIA, cilt.53, sa.1, ss.12-25, 2025 (SCI-Expanded, Scopus)
15. Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registryGEMİCİOĞLU B., GÖKMEN D., Can A., SEVİNÇ C., OĞUZÜLGEN İ. K., SOYYİĞİT Ş., et al.RESPIRATORY MEDICINE, cilt.236, 2025 (SCI-Expanded, Scopus)
16. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registryARSLAN B., TÜRK M., HAYME S., AYDIN Ö., GÖKMEN D., Buhari G. K., et al.CLINICAL AND TRANSLATIONAL ALLERGY, cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)
17. Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registryÇELEBİ SÖZENER Z., OĞUZÜLGEN İ. K., Ozalp Ates F. S., BAÇÇIOĞLU A., ARGUN BARIŞ S., EDİGER D., et al.JOURNAL OF ASTHMA, cilt.62, ss.1183-1194, 2025 (SCI-Expanded, Scopus)
18. Comparison of the Efficacy of Omalizumab and Mepolizumab in Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory DiseaseCİHANBEYLERDEN M., TUNCAY G., KAYIKÇI H., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, cilt.185, ss.947-952, 2024 (SCI-Expanded, Scopus)
19. Successful desensitization in a patient with recurrent anaplastic oligodendroglioma presenting with procarbazine-mediated anaphylaxisKAYIKÇI H., Can Bostan Ö., TUNCAY G., CİHANBEYLERDEN M., Tüccar Ç., DAMADOĞLU E., et al.Journal of Oncology Pharmacy Practice, cilt.30, sa.5, ss.937-940, 2024 (SCI-Expanded, Scopus)
20. Efficacy and Safety of Donidalorsen for Hereditary AngioedemaRiedl M. A., Tachdjian R., Lumry W. R., Craig T., KARAKAYA G., Gelincik A., et al.NEW ENGLAND JOURNAL OF MEDICINE, cilt.391, sa.1, ss.21-31, 2024 (SCI-Expanded, Scopus)
21. Efficacy and safety of hymenoptera venom immunotherapyKAYIKÇI H., Bostan O. C., TUNCAY G., CİHANBEYLERDEN M., DAMADOĞLU E., KARAKAYA G., et al.ALLERGY AND ASTHMA PROCEEDINGS, cilt.45, sa.4, ss.268-275, 2024 (SCI-Expanded, Scopus)
22. Assessment of clinical phenotypic characteristics of patients with angioedema without wheals in a turkish populationCakmak M. E., Bostan O. C., KAYA S. B., KARAKAYA G., KALYONCU A. F., DAMADOĞLU E.ALLERGY AND ASTHMA PROCEEDINGS, cilt.45, sa.4, ss.240-246, 2024 (SCI-Expanded, Scopus)
23. Clinical features, severity, and immunological changes during venom immunotherapy in children and adultsBuyuktiryaki B., Hela F., Ozturk A. B., DURSUN A. B., DÖNMEZ H., Gelincik A., et al.ALLERGY AND ASTHMA PROCEEDINGS, cilt.45, sa.4, ss.276-283, 2024 (SCI-Expanded, Scopus)
24. Elderly and aged asthma have different characteristics: results of a multicenter studyDAMADOĞLU E., ÖZTÜRK AKTAŞ Ö., GEMİCİOĞLU B., Yilmaz N., Bozkuş F., Ayhan V., et al.Turkish Journal of Medical Sciences, cilt.54, sa.1, ss.309-315, 2024 (SCI-Expanded, Scopus, TRDizin)
25. Inhaler Steroid Use Changes Oral and Airway Bacterial and Fungal Microbiome Profile in Asthma PatientsOĞUZÜLGEN İ. K., Öztürk A. B., Bacceoǧlu A., Aydln Ö., Köycü Buhari G., DAMADOĞLU E., et al.International Archives of Allergy and Immunology, cilt.185, sa.1, ss.10-19, 2024 (SCI-Expanded, Scopus)
26. Dual biologics therapy in a patient with severe asthma and chronic urticaria: a case report and review of the literatureCAN BOSTAN Ö., KARAKAYA G., KALYONCU A. F., DAMADOĞLU E.Journal of Asthma, cilt.61, sa.3, ss.260-264, 2024 (SCI-Expanded, Scopus)
27. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU studyKocatürk E., Salameh P., Sarac E., Vera Ayala C. E., Thomsen S. F., Zuberbier T., et al.Journal of Allergy and Clinical Immunology, cilt.152, sa.5, ss.1095-1106, 2023 (SCI-Expanded, Scopus)
28. Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management GroupÇELİK G. E., AYDIN Ö., DAMADOĞLU E., Baççıoğlu A., Özdemir S. K., BAVBEK S., et al.Thoracic Research and Practice, cilt.24, sa.6, ss.309-324, 2023 (ESCI, Scopus, TRDizin)
29. Reply to “Artificial intelligence's potential in tailoring prescription of biological therapy for chronic rhinosinusitis”Goktas P., KARAKAYA G., KALYONCU A. F., DAMADOĞLU E.Journal of Allergy and Clinical Immunology: In Practice, cilt.11, sa.10, ss.3286-3287, 2023 (SCI-Expanded, Scopus)
30. Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?Goktas P., KARAKAYA G., KALYONCU A. F., DAMADOĞLU E.Journal of Allergy and Clinical Immunology: In Practice, cilt.11, sa.9, ss.2697-2700, 2023 (SCI-Expanded, Scopus)
31. Validity and Reliability of the Turkish Version of the Nijmegen Questionnaire in Asthma.ÇAKMAK A., ŞİMŞEK S., İnce D., SAĞLAM M., ÇALIK KÜTÜKCÜ E., Yağlı N. V., et al.Thoracic research and practice, cilt.24, sa.4, ss.194-201, 2023 (ESCI, Scopus, TRDizin)
32. Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway diseaseCİHANBEYLERDEN M., CAN BOSTAN Ö., TUNCAY G., Safak C., DAMADOĞLU E., KARAKAYA G., et al.Allergy and asthma proceedings, cilt.44, sa.4, 2023 (SCI-Expanded, Scopus)
33. Biologics for the treatment of severe asthma: Current status report 2023ÇETİN G. P., ÖZDEMİR S. K., BOSTAN Ö. C., ÖZTOP N., Celebi Sozener Z., KARAKAYA G., et al.Tüberküloz ve Toraks, cilt.71, sa.2, ss.176-187, 2023 (ESCI, Scopus, TRDizin)
34. Thermo-SPT: A new skin prick test evaluation framework based on low-cost, portable smartphone thermographyGoktas P., CAN BOSTAN Ö., GÜLSEREN D., Cakmak M. E., KAYA S. B., DAMADOĞLU E., et al.Clinical and Experimental Allergy, cilt.53, sa.6, ss.626-635, 2023 (SCI-Expanded, Scopus)
35. Comparison of 300 mg versus 600 mg daily maintenance doses of aspirin treatment after desensitization in N-ERD: A three-year multicentre experienceÇELİK G. E., KARAKAYA G., Erkekol F. O., Dursun A. B., Gelincik A., AYDIN Ö., et al.Allergy and asthma proceedings, cilt.44, sa.2, ss.106-114, 2023 (SCI-Expanded, Scopus)
36. Physical activity and dietary habits in patients with asthma: How is it related to asthma control?AYDIN Ö., Çelebi Sözener Z., MUNGAN V. D., Özbey Ü., BALABAN S., GÖKMEN D., et al.Obesity Medicine, cilt.38, 2023 (Scopus)
37. How do we manage asthma? Assessment of knowledge, attitude, and practice patterns among pulmonologists and allergistsGÜNAYDIN F. E., AY N. P., KARAKAYA G., EDİGER D.JOURNAL OF ASTHMA, cilt.60, sa.1, ss.130-138, 2023 (SCI-Expanded, Scopus)
38. Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab TreatmentCan Bostan Ö., Damadoğlu E., Saraç B. E., Kılıç B., Şahiner Ü. M., Karaaslan İ. Ç., et al.Dermatology Practical and Conceptual, cilt.13, sa.4, 2023 (SCI-Expanded, Scopus)
39. Picturing asthma in Turkey: results from the Turkish adult asthma registryÇELİK G. E., AYDIN Ö., GÖKMEN D., Koycu Buhari G., Celebi Sozener Z., GEMİCİOĞLU B., et al.Journal of Asthma, cilt.60, sa.11, ss.1973-1986, 2023 (SCI-Expanded, Scopus)
40. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults: Beyond current classificationÇerçi P., Kendirlinan R., Büyüköztürk S., Gelincik A., Ünal D., Demir S., et al.Allergologia et immunopathologia, cilt.51, sa.5, ss.84-92, 2023 (SCI-Expanded, Scopus)
41. Short- and long-term oral steroid therapy in patients with asthma exacerbationÇakmak M. E., Kaya S. B., Bostan Ö. C., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.Monaldi Archives for Chest Disease, cilt.93, sa.1, 2023 (ESCI, Scopus)
42. Prevalence and clinical features of pollen-food allergy syndrome in adults with seasonal allergic rhinitisÖZDEMİR E., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.European Review for Medical and Pharmacological Sciences, cilt.27, sa.1, ss.103-109, 2023 (SCI-Expanded, Scopus)
43. Visual Analogue Scale is A Simple and Quick Too to Evaluate Drug Reaction SeverityÖZDEMİR E., KARABİBER E., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.ASTIM ALLERJI IMMUNOLOJI, cilt.20, ss.172-178, 2022 (ESCI, Scopus, TRDizin)
44. SARS-CoV-2 vaccines are well tolerated in patients with mastocytosisTUNCAY G., CAN BOSTAN Ö., KARAKAYA G., KALYONCU A. F.ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, cilt.128, sa.6, ss.733-734, 2022 (SCI-Expanded, Scopus)
45. Validity and reliability of 6-minute pegboard and ring test in patients with asthmaÇALIK KÜTÜKCÜ E., TEKERLEK H., BOZDEMİR ÖZEL C., Karaduz B. N., ÇAKMAK A., İNAL İNCE D., et al.JOURNAL OF ASTHMA, cilt.59, sa.7, ss.1387-1395, 2022 (SCI-Expanded, Scopus)
46. SARS-CoV-2 vaccines are well tolerated in patients with mastocytosisTUNCAY G., CAN BOSTAN Ö., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.Annals of Allergy, Asthma and Immunology, cilt.128, sa.6, ss.733-734, 2022 (SCI-Expanded, Scopus)
47. The association of timothy grass allergy and cat ownership on cat sensitizationCAN BOSTAN Ö., Cakmak M. E., Kaya S. B., TUNCAY G., DAMADOĞLU E., KARAKAYA G., et al.ALLERGY AND ASTHMA PROCEEDINGS, cilt.43, sa.3, ss.220-225, 2022 (SCI-Expanded, Scopus)
48. The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases?DURAN E., CAN BOSTAN Ö., BİLGİN E., KAYA S. B., BÖLEK E. Ç., ÖZER S., et al.INTERNAL AND EMERGENCY MEDICINE, cilt.17, sa.3, ss.743-751, 2022 (SCI-Expanded, Scopus)
49. Long-term natural course of patients with seasonal allergic rhinitisCakmak M. E., Kaya S. B., CAN BOSTAN Ö., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, cilt.9, sa.2, ss.106-114, 2022 (ESCI)
50. Impact of socioeconomic factors and house cleaning on asthma control in womenSertcelik U. O., DAMADOĞLU E., KARAKAYA G., DEMİR A. U., KALYONCU A. F.ALLERGY AND ASTHMA PROCEEDINGS, cilt.43, sa.2, ss.140-147, 2022 (SCI-Expanded, Scopus)
51. Hyperamylasemia During Omalizumab TherapyKarabiber E., Aktas O. O., Ozdemir E., DAMADOĞLU E., ŞAHİNER Ü. M., KARAKAYA G., et al.ASTIM ALLERJI IMMUNOLOJI, cilt.20, sa.1, ss.31-35, 2022 (ESCI, Scopus, TRDizin)
52. A new classification option for NSAID hypersensitivity: Kalyoncu classificationÖZDEMİR E., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.ALLERGOLOGIA ET IMMUNOPATHOLOGIA, cilt.50, sa.6, ss.122-127, 2022 (SCI-Expanded, Scopus)
53. Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent PatientsŞEKEREL B. E., ÜNSAL H., ŞAHİNER Ü. M., UYSAL SOYER Ö., DAMADOĞLU E., KARAKAYA G., et al.JOURNAL OF ASTHMA AND ALLERGY, cilt.15, ss.219-229, 2022 (SCI-Expanded, Scopus)
54. The course of COVID-19 in patients with severe asthma receiving biological treatmentTUNCAY G., Cakmak M. E., CAN BOSTAN Ö., KAYA S. B., DAMADOĞLU E., KARAKAYA G., et al.JOURNAL OF ASTHMA, cilt.59, sa.11, ss.2174-2180, 2022 (SCI-Expanded, Scopus)
55. Effect of COVID-19 on hereditary angioedema activity and quality of lifeCAN BOSTAN Ö., TUNCAY G., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.ALLERGY AND ASTHMA PROCEEDINGS, cilt.42, sa.5, ss.403-408, 2021 (SCI-Expanded, Scopus)
56. Regular Treatment With Aspirin 300 mg/day After Desensitization in Patients With N-ERD: 12-Year ResultsKAYA S. B., Cakmak M. E., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.TURKISH THORACIC JOURNAL, cilt.22, sa.5, ss.376-380, 2021 (ESCI, Scopus, TRDizin)
57. The Role of Skin Tests and Premedication in Radiocontrast Media Hypersensitivity: A Clinical DilemmaCAN BOSTAN Ö., Cakmak M. E., KAYA S. B., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.ASTIM ALLERJI IMMUNOLOJI, cilt.19, sa.2, ss.78-83, 2021 (ESCI, Scopus, TRDizin)
58. A practical method of drug provocation testing to prove tolerance to alternative drugs in drug hypersensitivityDAMADOĞLU E., Ozturk Aktas O., KARAKAYA G., KALYONCU A. F.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.2, ss.604-609, 2021 (SCI-Expanded, Scopus, TRDizin)
59. Allergic reactions due to concomitant administration of multiple drugs in intravenous fluid in emergency departments in TurkeyCakmak M. E., Kaya S. B., CAN BOSTAN Ö., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.EMERGENCY CARE JOURNAL, cilt.17, sa.3, 2021 (ESCI)
60. Country-based report: the safety of omalizumab treatment in pregnant patients with asthmaGEMİCİOĞLU B., Yalcin A. D., Havlucu Y., KARAKAYA G., Ozdemir L., Keren M., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.5, ss.2516-2523, 2021 (SCI-Expanded, Scopus, TRDizin)

All 94 on AVESİS →

1. Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory diseaseCihanbeylerden M., Bostan O. C., Tuncay G., Damadoglu E., KARAKAYA G., Kalyoncu A. F.Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Hamburg, Almanya, 9 - 11 Haziran 2023, ss.52, (Özet Bildiri)
2. Real-world patient-level costeffectiveness analysis of omalizumab in patients with severe allergic asthmaOĞUZÜLGEN İ. K., Tugay D., TOP M., AYDIN Ö., BAVBEK S., DAMADOĞLU E., et al.Annual congress of the European-Respiratory-Society (ERS), Milan, İtalya, 9 - 13 Eylül 2023, (Özet Bildiri)
3. A comparison of upper extremity functional exercise capacity and activities of daily living in patients with asthma and chronic obstructive pulmonary diseaseKaraduz B. N., ÇALIK KÜTÜKCÜ E., ÇAKMAK A., İNAL İNCE D., VARDAR YAĞLI N., SAĞLAM M., et al.European-Respiratory-Society (ERS) International Congress, Madrid, İspanya, 28 Eylül - 02 Ekim 2019, cilt.54, (Özet Bildiri)
4. Oto boya sektöründe çalışan boyacıların solunum fonksiyonlarının, fiziksel aktivite seviyelerinin, yaşam kalitelerinin ve günlük yaşam aktivitelerinin etkilenimiSERAY Ş. P., ARIKAN H., ÇIRAK Y., ÇALIK KÜTÜKCÜ E., ÇÖPLÜ L., KARAKAYA G.3. Uluslararası Sağlık Bilimleri Kongresi Bildiri Özeti Kitabı, 29 Kasım - 01 Aralık 2018, ss.249, (Özet Bildiri)
5. Comparison of fatigue, exercise capacity, physical activity, and quality of life in asthmatic patients with low and high symptom scoresSONBAHAR H., İNAL İNCE D., ÇAKMAK A., VARDAR YAĞLI N., BOZDEMİR ÖZEL C., SAĞLAM M., et al.28th European Respiratory Society Annual Congress, 15 - 19 Eylül 2018, cilt.52, ss.4597, (Özet Bildiri)
6. Are elderly and aged asthma different diseases? Results of a multicenter studyÇELEBİOĞLU E., Aktas O. O., GEMİCİOĞLU B., YILMAZ N., BOZKUŞ F., Ayhan V., et al.28th International Congress of the European-Respiratory-Society (ERS), Paris, Fransa, 15 - 19 Eylül 2018, cilt.52, (Özet Bildiri)
7. Düşük ve yüksek aktivite limitasyonu skoru olan astım hastalarında yorgunluk, ortalama quadriseps kas kuvveti ve yaşam kalitesinin karşılaştırılmasıSONBAHAR H., İNAL İNCE D., VARDAR YAĞLI N., ÇAKMAK A., SAĞLAM M., BOZDEMİR ÖZEL C., et al.XVII. Fizyoterapi ve Rehabilitasyonda Gelişmeler Kongresi, Türkiye, 25 - 28 Nisan 2018, cilt.29, ss.93, (Özet Bildiri)
8. Herediter Anjioödem Tip III ön tanılı hastalarda Faktör XII gen mutasyonlarıBİRBEN E., KARAKAYA G., ARIK YILMAZ E., BAVBEK S., DURSUN A. B., ŞAHİNER Ü. M., et al.XXIII. Ulusal Allerji ve İmmünoloji Kongresi, Türkiye, 8 - 12 Ekim 2016, (Özet Bildiri)
9. A comparison of extrapulmonary features in patients with asthma and healthy individualsSONBAHAR H., İNAL İNCE D., SAĞLAM M., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., BOZDEMİR ÖZEL C., et al.25th European Respiratory Society Annual Congress, 26 Eylül - 30 Kasım 2015, cilt.46, ss.970, (Özet Bildiri)
10. Bronşiyal Astımlı Hastalarda Dispne Algılaması İskelet Kas Kuvveti Fiziksel Aktivite ve Yaşam Kalitesi İlişkisiSONBAHAR H., İNAL İNCE D., SAĞLAM M., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., BOZDEMİR ÖZEL C., et al.Türk Toraks Derneği 18.Yıllık Kongresi, Türkiye, 1 - 05 Nisan 2015, (Özet Bildiri)
11. Determinants of fatigue in patients with bronchial asthmaİNAL İNCE D., SAVCI S., VARDAR YAĞLI N., SAĞLAM M., ÇALIK KÜTÜKCÜ E., BOŞNAK GÜÇLÜ M., et al.23rd European Respiratory Society Annual Congress, 7 - 11 Eylül 2013, cilt.42, ss.1076
12. Astımda sirkadyan ritm tipinin solunum fonksiyonları dispne ve yaşam kalitesine etkileriŞAHİN E., İNAL İNCE D., VARDAR YAĞLI N., SAĞLAM M., ÇALIK E., SAVCI S., et al.Türk Toraks Derneği 16.Yıllık Kongresi, Türkiye, 3 - 07 Nisan 2013, cilt.14, ss.284
13. Acil Serviste Hasta GüvenliğiMETİN AKSU N., AKKAŞ M., KUNT M. M., KARACA M. A., ERBİL B., KARAKAYA G., et al.VII. Türkiye Acil Tıp Kongresi, Trabzon, Türkiye, 13 - 16 Ekim 2011, ss.88-89
14. Investigatiıon of patients with mild head injury asessed by cumputed tomography scan according to The Canadian Head CT Rules and The New Orleans Criteria in emergency departmentAyan C., KARACA M. A., AKPINAR E., KARAKAYA G.The 2nd EurAsian Congress on Emergency Medicine, Antalya, Türkiye, 28 - 31 Ekim 2010, ss.134
15. Triage System and Patients Information System in Hacettepe University Emergency ServiceKARACA M. A., KUNT M. M., ERBİL B., Karakılıç E., KARAKAYA G.The 2nd Eurasian Congress on Emergency Medicine, Antalya, Türkiye, 28 - 31 Ekim 2010, ss.38-40
16. Astımda Nefes Darlığını Azaltmada Kişisel Yönetim Yaklaşımlarının KullanımıARIKAN H., İNAL İNCE D., VARDAR YAĞLI N., SAVCI S., SAĞLAM M., ÇALIK E., et al.Toraks Derneği 13. Yıllık Kongresi, Türkiye, 5 - 09 Mayıs 2010, cilt.1, ss.347
17. Profile of Patients with Inborn Errors of Immunity Managed in an Adult Transition ClinicÖZTÜRK AKTAŞ Ö., ŞAHAN Ö., DAMADOĞLU E., KARAKAYA G., ÇAĞDAŞ AYVAZ D. N., KALYONCU A. F.
18. COMPLEMENT FACTOR I DEFICIENCY MAY PRESENT WITH RECURRENT SEIZURES AND ENCEPHALITISŞAHAN Ö., ÖZTÜRK AKTAŞ Ö., YAZ İ., DAMADOĞLU E., KARAKAYA G., ÇAĞDAŞ AYVAZ D. N., et al.
19. Association between disease severity, asthma control and obesity in children and adultsKAHVECİ M., ÇAKMAK M., KAYA S., Soyer Ö., ÇELEBİOĞLU E., ŞAHİNER Ü. M., et al.
20. Physical social and psychological function in asthma patients with and without analgesic toleranceİNAL İNCE D., SAVCI S., VARDAR YAĞLI N., ÇALIK E., SAĞLAM M., ARIKAN H., et al.
21. Obstrüktif akciğer hastalarında solunum kas eğitiminin solunum kas kuvveti ve fonksiyonel kapasiteye etkisiARIKAN H., BOŞNAK GÜÇLÜ M., İNAL İNCE D., SAVCI S., SAĞLAM M., VARDAR YAĞLI N., et al.